Margaret Karow

9.2k total citations · 3 hit papers
35 papers, 5.7k citations indexed

About

Margaret Karow is a scholar working on Genetics, Immunology and Molecular Biology. According to data from OpenAlex, Margaret Karow has authored 35 papers receiving a total of 5.7k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Genetics, 14 papers in Immunology and 13 papers in Molecular Biology. Recurrent topics in Margaret Karow's work include Bacterial Genetics and Biotechnology (10 papers), RNA and protein synthesis mechanisms (6 papers) and Monoclonal and Polyclonal Antibodies Research (5 papers). Margaret Karow is often cited by papers focused on Bacterial Genetics and Biotechnology (10 papers), RNA and protein synthesis mechanisms (6 papers) and Monoclonal and Polyclonal Antibodies Research (5 papers). Margaret Karow collaborates with scholars based in United States, France and Switzerland. Margaret Karow's co-authors include George D. Yancopoulos, Andrew Murphy, David M. Valenzuela, Richard A. Flavell, Jennifer M. Lund, Ayuko Sato, Lena Alexopoulou, Niels C. Adams, Akiko Iwasaki and Costa Georgopoulos and has published in prestigious journals such as Cell, Proceedings of the National Academy of Sciences and Circulation.

In The Last Decade

Margaret Karow

35 papers receiving 5.6k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Recognition of single-stranded RNA viruses by Toll-like receptor 7

2004 1.4k citations Margaret Karow, Richard A. Flavell et al. Proceedings of the National Academy of Sciences profile →
SIRT4 Inhibits Glutamate Dehydrogenase and Opposes the Effects of Calorie Restriction in Pancreatic β Cells

2006 930 citations Andrew Murphy, David M. Valenzuela et al. profile →
Interleukin-22 but Not Interleukin-17 Provides Protection to Hepatocytes during Acute Liver Inflammation

2007 522 citations Lauren A. Zenewicz, George D. Yancopoulos et al. Immunity profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Margaret Karow United States	27	2.6k	1.6k	1.2k	946	769	35	5.7k
F. Xiao‐Feng Qin China	41	3.8k 1.5×	2.6k 1.6×	885 0.7×	948 1.0×	727 0.9×	115	8.0k
Anthony Rongvaux United States	32	3.2k 1.2×	2.7k 1.7×	925 0.8×	473 0.5×	593 0.8×	51	6.5k
Yujing Bi China	35	1.4k 0.5×	1.5k 0.9×	366 0.3×	349 0.4×	486 0.6×	119	3.4k
Georges Herbein France	46	2.4k 0.9×	1.4k 0.9×	1.7k 1.4×	260 0.3×	305 0.4×	132	6.2k
Rhea Sumpter United States	21	1.6k 0.6×	2.3k 1.4×	3.4k 2.8×	307 0.3×	192 0.2×	26	5.9k
Hiroko Omori Japan	21	1.8k 0.7×	2.8k 1.8×	4.1k 3.3×	477 0.5×	313 0.4×	36	6.7k
Felix Randow United Kingdom	39	3.5k 1.3×	3.8k 2.4×	4.0k 3.3×	466 0.5×	359 0.5×	51	8.7k
Makoto Miyagishi Japan	45	5.9k 2.3×	7.2k 4.6×	1.7k 1.4×	466 0.5×	1.3k 1.7×	131	12.9k
Sidong Xiong China	45	2.7k 1.1×	2.7k 1.7×	1.3k 1.1×	204 0.2×	325 0.4×	208	6.4k
Zhi‐Ming Zheng United States	46	735 0.3×	4.0k 2.5×	2.6k 2.1×	227 0.2×	436 0.6×	149	7.1k

Countries citing papers authored by Margaret Karow

Since Specialization

Citations

This map shows the geographic impact of Margaret Karow's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Margaret Karow with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Margaret Karow more than expected).

Fields of papers citing papers by Margaret Karow

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Margaret Karow. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Margaret Karow. The network helps show where Margaret Karow may publish in the future.

Co-authorship network of co-authors of Margaret Karow

This figure shows the co-authorship network connecting the top 25 collaborators of Margaret Karow. A scholar is included among the top collaborators of Margaret Karow based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Margaret Karow. Margaret Karow is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Park, Miso, Magali Pederzoli-Ribeil, Uğur Eskiocak, et al.. (2023). XTX101, a tumor-activated, Fc-enhanced anti-CTLA-4 monoclonal antibody, demonstrates tumor-growth inhibition and tumor-selective pharmacodynamics in mouse models of cancer. Journal for ImmunoTherapy of Cancer. 11(12). e007785–e007785. 8 indexed citations

Zhang, Minjie, Uğur Eskiocak, M. A. McLaughlin, et al.. (2020). 587 Tumor-activated Fc-engineered anti-CTLA-4 monoclonal antibody, XTX101, demonstrates tumor-selective PD and efficacy in preclinical models. SHILAP Revista de lepidopterología. A351.2–A351. 2 indexed citations

Murphy, Andrew, Lynn E. Macdonald, Sean Stevens, et al.. (2014). Mice with megabase humanization of their immunoglobulin genes generate antibodies as efficiently as normal mice. Proceedings of the National Academy of Sciences. 111(14). 5153–5158. 307 indexed citations

Foltz, Ian N., Margaret Karow, & Scott M. Wasserman. (2013). Evolution and Emergence of Therapeutic Monoclonal Antibodies. Circulation. 127(22). 2222–2230. 70 indexed citations

Azuma, Yasu‐Taka, Yukiko Matsuo, Hidemitsu Nakajima, et al.. (2010). Interleukin-19 Is a Negative Regulator of Innate Immunity and Critical for Colonic Protection. Journal of Pharmacological Sciences. 115(2). 105–111. 27 indexed citations

Azuma, Yasu‐Taka, Yukiko Matsuo, Mitsuru Kuwamura, et al.. (2009). Interleukin-19 protects mice from innate-mediated colonic inflammation. Inflammatory Bowel Diseases. 16(6). 1017–1028. 97 indexed citations

Towne, Charles F., Ian A. York, Joost Neijssen, et al.. (2008). Puromycin-Sensitive Aminopeptidase Limits MHC Class I Presentation in Dendritic Cells but Does Not Affect CD8 T Cell Responses during Viral Infections. The Journal of Immunology. 180(3). 1704–1712. 32 indexed citations

Zenewicz, Lauren A., George D. Yancopoulos, David M. Valenzuela, et al.. (2007). Interleukin-22 but Not Interleukin-17 Provides Protection to Hepatocytes during Acute Liver Inflammation. Immunity. 27(4). 647–659. 522 indexed citations breakdown →

Mishra, Anil, Meiqin Wang, Nikolaos M. Nikolaidis, et al.. (2007). Resistin-like molecule-β is an allergen-induced cytokine with inflammatory and remodeling activity in the murine lung. American Journal of Physiology-Lung Cellular and Molecular Physiology. 293(2). L305–L313. 57 indexed citations

10.

Becker, Christoph, Heike Dornhoff, Clemens Neufert, et al.. (2006). Cutting Edge: IL-23 Cross-Regulates IL-12 Production in T Cell-Dependent Experimental Colitis. The Journal of Immunology. 177(5). 2760–2764. 186 indexed citations

11.

Becker, Christian, Heike Dornhoff, Clemens Neufert, et al.. (2006). IL-23 cross-regulates IL-12 production in T cell dependent experimental colitis. Zeitschrift für Gastroenterologie. 44(8). 6 indexed citations

12.

Hogan, Simon P., Luqman Seidu, Carine Blanchard, et al.. (2006). Resistin-like molecule β regulates innate colonic function: Barrier integrity and inflammation susceptibility. Journal of Allergy and Clinical Immunology. 118(1). 257–268. 131 indexed citations

13.

Pope, Samuel M., Nives Zimmermann, Keith Stringer, Margaret Karow, & Marc E. Rothenberg. (2005). The Eotaxin Chemokines and CCR3 Are Fundamental Regulators of Allergen-Induced Pulmonary Eosinophilia. The Journal of Immunology. 175(8). 5341–5350. 194 indexed citations

14.

Karow, Margaret & Patrick J. Piggot. (1995). Construction of gusA transcriptional fusion vectors for Bacillus subtilis and their utilization for studies of spore formation. Gene. 163(1). 69–74. 59 indexed citations

15.

Karow, Margaret & Costa Georgopoulos. (1993). The essential Escherichia coli msbA gene, a multicopy suppressor of null mutations in the htrB gene, is related to the universally conserved family of ATP‐dependent translocators. Molecular Microbiology. 7(1). 69–79. 124 indexed citations

16.

Karow, Margaret & Costa Georgopoulos. (1992). Isolation and characterization of the Escherichia coli msbB gene, a multicopy suppressor of null mutations in the high-temperature requirement gene htrB. Journal of Bacteriology. 174(3). 702–710. 100 indexed citations

17.

Karow, Margaret, Olivier Fayet, & Costa Georgopoulos. (1992). The lethal phenotype caused by null mutations in the Escherichia coli htrB gene is suppressed by mutations in the accBC operon, encoding two subunits of acetyl coenzyme A carboxylase. Journal of Bacteriology. 174(22). 7407–7418. 45 indexed citations

18.

Karow, Margaret & Costa Georgopoulos. (1991). Sequencing, mutational analysis, and transcriptional regulation of the Escherichia coli htrB gene. Molecular Microbiology. 5(9). 2285–2292. 43 indexed citations

19.

Karow, Margaret, Satish Raina, Costa Georgopoulos, & Olivier Fayet. (1991). Complex phenotypes of null mutations in the htr genes, whose products are essential for Escherichia coli growth at elevated temperatures. Research in Microbiology. 142(2-3). 289–294. 17 indexed citations

20.

Hazelrigg, Tulle, et al.. (1990). The exuperantia gene is required for Drosophila spermatogenesis as well as anteroposterior polarity of the developing oocyte, and encodes overlapping sex-specific transcripts.. Genetics. 126(3). 607–617. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact